-
May 28, 2013
Australian patients are missing out on some new medicines because the process of listing them on the Pharmaceutical Benefit Scheme (PBS) has become too difficult, say industry leaders.
Full story
-
May 03, 2012
13 medicines on Australia's Pharmaceutical Benefits Scheme (PBS), accounting for more than 200 brands, have taken new price cuts of between 11% and 77%.
Full story
-
April 13, 2012
The biggest round of price cuts in the history of Australia's PBS, coupled with historically low spending growth, means that there is no need for any further PBS cuts in next month's Federal Budget, the government has been told.
Full story
-
February 23, 2012
If Australia had paid English prices for generic simvastatin during May 2010-October 2011, its PBS spending could have been reduced from $150 million to just A$20 million, says a leading health economist.
Full story
-
November 14, 2011
There is no case for any further cuts to be made to spending under the Pharmaceutical Benefits Scheme (PBS), say Australia's pharmacy and drug manufacturing sectors.
Full story
-
February 23, 2011
The Australian pharmaceutical industry landscape is set to change dramatically as a result of government changes to the Pharmaceutical Benefits Scheme (PBS), says a new report.
Full story